- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AKCEA-ANGPTL3-LRx
Total 564 results
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Chylomicronemia Syndrome | Lipoprotein Lipase Deficiency | Hyperlipoproteinemia Type 1Canada
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.WithdrawnHomozygous Familial HypercholesterolemiaCanada
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Partial LipodystrophyUnited States
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedDiabetes Mellitus, Type 2 | NAFLD | Hypertriglyceridemia | Fatty Liver, NonalcoholicUnited States, Canada
-
Ionis Pharmaceuticals, Inc.RecruitingHereditary Transthyretin-Mediated Amyloid PolyneuropathyUnited States, Italy, Portugal, Spain, Taiwan, Sweden, Canada, Brazil, France, New Zealand, Argentina, Cyprus, Australia, Turkey
-
Ionis Pharmaceuticals, Inc.Active, not recruitingTransthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)United States, Australia, Spain, Canada, Germany, Japan, Italy, Israel, Argentina, France, Portugal, Austria, Brazil, Greece, United Kingdom, Czechia, Sweden, Belgium, Denmark, Poland, Puerto Rico
-
Ionis Pharmaceuticals, Inc.Completed
-
Ionis Pharmaceuticals, Inc.Active, not recruitingFamilial Chylomicronemia SyndromeSpain, United Kingdom, France, Canada, United States, Italy, Netherlands, Norway, Portugal, Slovakia, Sweden
-
Ionis Pharmaceuticals, Inc.RecruitingSevere HypertriglyceridemiaUnited States, South Africa, Spain, Israel, Australia, Sweden, Netherlands, Canada, Poland, Denmark, Hungary, Bulgaria, Czechia, Italy, France, Norway, New Zealand, Slovakia, Turkey
-
Ionis Pharmaceuticals, Inc.Active, not recruitingFamilial Chylomicronemia SyndromeUnited States, Canada, Sweden
-
Ionis Pharmaceuticals, Inc.Active, not recruitingSevere HypertriglyceridemiaFinland, United States, France, Israel, Netherlands, Denmark, Spain, Australia, United Kingdom, Germany, Italy, Canada, Czechia, Turkey, Hungary, Bulgaria, New Zealand, Sweden, South Africa, Poland, Norway, Portugal, Slovakia
-
Ionis Pharmaceuticals, Inc.Active, not recruitingCardiovascular Diseases | Atherosclerosis | HypertriglyceridemiaUnited States, Spain, Italy, Denmark, Hungary, Netherlands, Canada, France, Poland, Bulgaria, Czechia, Portugal, Slovakia, Norway
-
Ionis Pharmaceuticals, Inc.RecruitingSevere HypertriglyceridemiaUnited States, Belgium, Spain, Poland, Taiwan, France, Bulgaria, Netherlands, Brazil, Italy, Czechia, Canada, Greece, Portugal, Argentina, Malaysia, Mexico, Slovakia, Sweden, Hungary, India, Romania, Lithuania
-
Ionis Pharmaceuticals, Inc.CompletedHypertriglyceridemia | Atherosclerotic Cardiovascular Disease | Severe HypertriglyceridemiaUnited States, Canada
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompletedFamilial Chylomicronemia SyndromeUnited States, Israel, Spain, Italy, United Kingdom, Netherlands, Canada, Hungary, Sweden, France, Norway, Portugal, Slovakia
-
Ionis Pharmaceuticals, Inc.CompletedHereditary Transthyretin-Mediated Amyloid PolyneuropathyUnited States, Spain, Taiwan, Italy, Germany, Argentina, Australia, Brazil, Canada, Cyprus, France, Greece, New Zealand, Portugal, Sweden, Turkey
-
Ionis Pharmaceuticals, Inc.CompletedHealthy ParticipantsUnited States
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedCardiovascular Diseases | HypertriglyceridemiaUnited States, Canada
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompletedHypertriglyceridemia | Familial HypercholesterolemiaCanada
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedCardiovascular Disease | Elevated Lipoprotein(a)United States, Canada, Denmark, Germany, Netherlands
-
Ionis Pharmaceuticals, Inc.CompletedHealthy Volunteers | hATTR AmyloidosisCanada
-
University of ChicagoNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
University of South WalesPublic Health Wales; Cwm Taf University Health BoardSuspendedCardiovascular Diseases | Health Behavior | Cardiovascular Risk FactorUnited Kingdom
-
University of ChicagoNational Institute on Aging (NIA)Enrolling by invitation
-
Ionis Pharmaceuticals, Inc.Completed
-
Ionis Pharmaceuticals, Inc.Completed
-
Ionis Pharmaceuticals, Inc.CompletedHealthy VolunteersCanada
-
Ionis Pharmaceuticals, Inc.RecruitingPhlebotomy Dependent Polycythemia VeraUnited States, Canada, Hungary, United Kingdom, Australia, Poland
-
Ionis Pharmaceuticals, Inc.AvailableHereditary Angioedema
-
Ionis Pharmaceuticals, Inc.TerminatedBeta Thalassemia IntermediaAustralia, Thailand, Greece, Lebanon, Turkey
-
Ionis Pharmaceuticals, Inc.RecruitingHereditary AngioedemaUnited States, Puerto Rico, Belgium, Bulgaria, Canada, France, Germany, Israel, Italy, Netherlands, Poland, Spain, Turkey, United Kingdom
-
Ionis Pharmaceuticals, Inc.CompletedPrimary IgA NephropathyCanada, Australia, New Zealand, Singapore
-
Ionis Pharmaceuticals, Inc.Active, not recruitingHereditary AngioedemaNetherlands, United States
-
Ionis Pharmaceuticals, Inc.CompletedAcromegalyUnited States, Hungary, Serbia, Estonia, Italy, Latvia, Lithuania, Poland, Romania, Russian Federation
-
Ionis Pharmaceuticals, Inc.CompletedAcromegalyUnited States, Hungary, Serbia, Romania, Russian Federation, Lithuania, Poland
-
Ionis Pharmaceuticals, Inc.Completed
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompleted
-
Revibe TechnologiesCompleted
-
Ionis Pharmaceuticals, Inc.WithdrawnGeographic Atrophy | Age Related Macular DegenerationAustralia, United States, New Zealand
-
Ionis Pharmaceuticals, Inc.CompletedChronic Heart Failure With Reduced Ejection FractionUnited States, Hungary, Poland
-
Ionis Pharmaceuticals, Inc.Active, not recruitingMacular Degeneration | Geographic AtrophyUnited States, Spain, Australia, Austria, Canada, Czechia, Netherlands, New Zealand, Poland
-
Ionis Pharmaceuticals, Inc.Completed
-
Ionis Pharmaceuticals, Inc.CompletedHereditary AngioedemaUnited States, Netherlands
-
Johns Hopkins UniversityNational Institutes of Health (NIH); National Library of Medicine (NLM)Completed
-
Ionis Pharmaceuticals, Inc.Completed
-
University of South WalesPublic Health Wales; Cwm Taf University Health Board (NHS)SuspendedCardiovascular Diseases | Cardiovascular Risk Factor | Behavior, Health | Behavior Change InterventionsUnited Kingdom
-
EpicentRx, Inc.CompletedBrain MetastasesUnited States
-
Naurex, Inc, an affiliate of Allergan plcCompletedMajor Depressive DisorderUnited States
-
Naurex, Inc, an affiliate of Allergan plcCompletedMajor Depressive DisorderUnited States
-
Philips Clinical & Medical Affairs GlobalRecruiting